← Earnings Calls
FSLR FY2025 Q4 Improving

First Solar, Inc. earnings call

Feb 24, 2026 · 16:30 ET Alex BradleyByron JeffersMark Widmar earningscall_biz
Buzzberg read

CURE rollout begins next month, targeting 8% more energy yield than TOPCon

First Solar reported record 2025 results, with revenue and EPS at the high end of guidance, and provided a 2026 outlook that projects slightly lower revenue but a significantly higher gross margin driven by $2.1B+ in 45X tax credits. Management was tactically long-term, emphasizing a fully allocated US production position, a large contracted backlog, and the optionality of curtailed Southeast Asian capacity as it awaits the outcome of trade policy and IP litigation. FY2025 revenue of $5.2B and EPS of $14.21 were at the top end of guidance.

Buzzberg read CURE rollout begins next month, targeting 8% more energy yield than TOPCon First Solar reported record 2025 results, with revenue and EPS at the high end of guidance, and provided a 2026 outlook that projects slightly lower revenue but a significantly higher gross margin driven by $2.1B+ in 45X tax credits. Management was tactically long-term, emphasizing a fully allocated US production position, a large contracted backlog, and the optionality of curtailed Southeast Asian capacity as it awaits the outcome of trade policy and IP litigation. FY2025 revenue of $5.2B and EPS of $14.21 were at the top end of guidance. Read full analysisCollapse analysis

First Solar reported record 2025 results, with revenue and EPS at the high end of guidance, and provided a 2026 outlook that projects slightly lower revenue but a significantly higher gross margin driven by $2.1B+ in 45X tax credits. Management was tactically long-term, emphasizing a fully allocated US production position, a large contracted backlog, and the optionality of curtailed Southeast Asian capacity as it awaits the outcome of trade policy and IP litigation. FY2025 revenue of $5.2B and EPS of $14.21 were at the top end of guidance.

  • FY2026 revenue guided to $4.9-5.2B, with gross margin ~49.5% due to Section 45X tax credits.
  • Backlog stands at 50.1 GW, providing a multi-year revenue and earnings visibility cushion.
  • Management is curtailing Southeast Asian production, creating ~$1B in underutilization and startup costs as it bets on trade policy tailwinds.
Revenue$1.6828BReported
EPS$4.84Reported
Gross margin39.54%Reported
Operating margin32.56%Reported
6 grounded callouts

What matters now

The highest-signal changes from the call.

01
Technology

CURE rollout begins next month, targeting 8% more energy yield than TOPCon

02
Pricing

Booked 1 GW US at 36.4 cents per watt with adders

03
Legal

Filing ITC complaint against 10 groups over TopCon patent infringement

Show 3 more callouts
04
Margins

Tariffs and warehousing weigh on margins, but path to 20% core exists

05
Technology

Perovskite pilot line operational in early 2027, Oxford PV license secured

06
Margins

India production yields high teens to low 20% gross margin

Reported period

Actuals

MetricReportedChange
Revenue$1.6828BReported
EPS$4.84Reported
Gross margin39.54%Reported
Operating margin32.56%Reported
Free cash flow$1.0702BReported
Capex$0.1717BReported
Forward-looking

Forward guidance

MetricPeriodRangeMidpointStatus
CapexFY2026$0.8B–$1B$0.9BGuided
Gross marginFY2026$2.5B–$2.6B$2.55BGuided
RevenueFY2026$4.9B–$5.2B$5.05BGuided
AI, capex & demand read

Management read

Tone

Cautiously Confident

Management emphasized a strong backlog and balance sheet while highlighting ongoing policy, tariff, and underutilization headwinds, projecting a steady path to improve margins.

Capex

Investment and capacity

Management guided 2026 capital expenditures to $0.8–$1.0 billion, with roughly half supporting capacity expansion, primarily the South Carolina finishing line and the Louisiana plant. The remainder is split evenly between CURE in India and R&D technology replication and maintenance.

all 4 named companies below

Companiesreturns since call

Customers

Customers

BP's contract breach and subsequent termination negatively impacted First Solar's 2025 financials, and the two are now entangled in litigation.

Evidence
“the termination amounts recognized in the third quarter related to the breach of contracts by affiliates of BP.”
Alex Bradley

Competitors

Competitors

US Customs is suggesting that no panels imported during the two-year ADCVD moratorium qualified for the moratorium, implying retroactive tariffs could be a significant financial liability for foreign producers that relied on it. — Retroactive tariff collection would significantly raise costs for importers of Chinese-tied panels, potentially making them less competitive and disrupting existing contracts in the US.

Evidence
“this is a separate action from our three actions seeking monetary damages against affiliates of Adani, Canadian Solar, and JNCO in the U.S. District Court.”
Mark Widmar

Supply chain

Supply chain

The US ITC case on TopCon patents, if successful, could result in a General Exclusion Order blocking imports of infringing TopCon products from all foreign entities, which is a potentially more sweeping action than a limited exclusion order. — A general exclusion order would be a substantial supply shock for the US solar market, potentially tightening supply and benefiting US domestic producers like First Solar.

Evidence
“the recently reported 236 million settlement entered in between Maxion and IACO. just days before a U.S. patent court was due to decide their patent dispute.”
Mark Widmar
External signals

Supply-chain alpha · 3returns since call

A1

The US ITC case on TopCon patents, if successful, could result in a General Exclusion Order blocking imports of infringing TopCon products from all foreign entities, which is a potentially more sweeping action than a limited exclusion order.

Evidence
“If the IETC institutes an investigation based on our complaint, we expect that the matter would be decided in approximately 18 months. If our case is successful, the ITC may issue a general exclusion order preventing the importation of inf…”
A2

US Customs is suggesting that no panels imported during the two-year ADCVD moratorium qualified for the moratorium, implying retroactive tariffs could be a significant financial liability for foreign producers that relied on it.

Evidence
“one recent industry publication noted that, quote, U.S. Customs is suggesting that no panels that came in during the moratorium qualified for the moratorium.”
A3

The near-total curtailment of First Solar's Southeast Asian factories is acting as a strategic option, preserving capacity for potential supply constraints driven by policy, but is creating significant underutilization costs and warehousing expenses in 2026.

Evidence
“we are looking at this as really an option to allow some of these potential tailwinds around 232 and other things to play itself out. to see what the impact of that could be to create more demand for those international operations.”
Methodology & coverage

Management-only analysis. All 4 validated company mentions are shown. Reported actuals and forward guidance are kept separate. Public evidence is limited to eight short attributed quotes. AI-generated analysis can be incomplete or wrong; verify important claims against the original source.